Stocks and Investing Stocks and Investing
Thu, December 1, 2022
Wed, November 30, 2022

Swayampakula Ramakanth Maintained (XFOR) at Strong Buy with Increased Target to $5 on, Nov 30th, 2022


Published on 2024-10-28 00:22:47 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Increased Target from $3.5 to $5 on, Nov 30th, 2022.

Swayampakula, nor any peers, have made any analyst calls on XFOR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources